Expert consensus on homogenization construction and management of pharmaceutical care in urban medical groups
- VernacularTitle:城市医疗集团药学服务同质化建设与管理专家共识
- Author:
Xiaoyan ZHANG
1
;
Bing LIU
2
;
Xin LI
3
;
Erxia SHI
4
;
Zhong LI
5
;
Yanli LEI
6
;
Shuai LIU
7
;
Shuyao ZHANG
1
;
Huishu TIAN
1
Author Information
1. Dept. of Pharmacy，Guangzhou Red Cross Hospital （the Fourth Clinical Medical College of Guangdong Pharmaceutical University），Guangzhou，510220，China
2. School of Pharmacy，Guangdong Pharmaceutical University，Guangzhou 510006，China
3. Dept. of Pharmacy，the Third Hospital of Changsha，Changsha 410015，China
4. Dept. of Pharmacy，the First Hospital of Hohhot，Hohhot 010030，China
5. Dept. of Pharmacy，Dalian Women and Children’s Medical Center （Group），Liaoning Dalian 116033，China
6. Dept. of Pharmacy，the Second People’s Hospital of Bijie，Guizhou Bijie 551700
7. School of Pharmacy，Jinan University，Guangzhou 510632，China
- Publication Type:Journal Article
- Keywords:
urban medical groups;
pharmaceutical care;
homogenization;
chief pharmacist system
- From:
China Pharmacy
2026;37(12):1528-1534
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To provide standardized guidance for the homogenization construction and management of pharmaceutical care in urban medical groups. METHODS This consensus was jointly initiated by the Therapeutic Drug Monitoring Professional Committee of the Chinese Pharmacological Society and the Expert Committee on Precision Clinical Medication of the Guangdong Pharmaceutical Association. Led by Guangzhou Red Cross Hospital， a drafting group of 7 members and an expert group of 36 members were organized. The outline of the Expert Consensus on Homogeneous Construction and Management of Pharmaceutical Care in Urban Medical Groups （hereinafter referred to as the “Consensus”） was discussed and finalized using the nominal group technique， and a preliminary draft was formed. The Delphi method was used for online c orrespondence review， and 12 external experts were invited for evaluation. After analyzing and revising expert opinions， the final Consensus was formed. RESULTS &CONCLUSIONS This Consensus defines the position setting and appointment procedures for the chief pharmacist， and establishes a three-tier professional guidance network of “chief pharmacist-regional/specialist pharmacist-pharmaceutical liaison of member institutions”. It formulates unified management standards for the drug supply catalog， establishes a full-process homogenization mechanism for prescription review， prescription commentation and comprehensive pharmaceutical care， and specifies the core functions and performance requirements of the prescription review system. It also supports by long-term mechanisms including cost allocation and performance assessment. This consensus can serve as a systematic reference for the homogeneous construction and management of pharmaceutical care systems in urban medical groups.
